Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes. Diabetes Care 2025;48:444

KORNELIUS EDY2026-10-162026-10-162025-08-01Pure ID: 15460408Pure UUID: 94f275ab-30b3-4acb-8a49-511c42053a9510.2337/dc25-0451https://www.scopus.com/pages/publications/105012146738https://scholars.csmu.edu.tw/handle/123456789/29902enGlucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes. Diabetes Care 2025;48:444–454journal article